Brief: Goldman Sachs Group's Long Position In Zhaoke Ophthalmology Rises To 5.20% - HKEX Filing
May 21 (Reuters) - Hong Kong stock exchange filing:
* GOLDMAN SACHS GROUP INC BOUGHT 1.57 MLN SHARES IN ZHAOKE
OPHTHALMOLOGY 6622.HK AT AVG PRICE OF HK$11.346 ($1.46) PER
SHARE ON MAY 17 - HKEX FILING
* GOLDMAN SACHS GROUP INC'S LONG POSITION IN ZHAOKE
OPHTHALMOLOGY
RISES TO 5.20% FROM 4.90% - HKEX FILING
Source text in English: https://bit.ly/3u77QtG
Further company coverage: 6622.HK
($1 = 7.7647 Hong Kong dollars)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital